Alvotech

FDA

Pharma

Novo, Alvotech written up after FDA site inspections

From Indiana to Iceland, the FDA disclosed concerns raised during recent visits to a pair of manufacturing sites with troubled regulatory histories.

Fraiser Kansteiner Jul 17, 2026 10:56am

Evolution step-up growth trajectory upward trajectory

How biosimilar developers are embracing next phase of US market

Jul 6, 2026 10:03am

Eggs in an incubator

New egg-based drugmaker Neion Bio strikes biosimilar collab

Mar 26, 2026 1:00pm

Businesspeople reaching agreement

Partners Alvotech, Teva eye 2026 Eylea biosimilar launch

Dec 19, 2025 10:40am

red light stop light street traffic signal

Alvotech plant issues trigger another FDA biosimilar rejection

Nov 4, 2025 7:40am

launch button

Teva and Alvotech's Humira biosimilar finally snags FDA approval

Feb 23, 2024 9:00pm